Integrated BioTherapeutics
Founded Year
2005Stage
Unattributed - II | AliveTotal Raised
$8.78MLast Raised
$50K | 1 yr agoAbout Integrated BioTherapeutics
Integrated BioTherapeutics focuses on the discovery of vaccines and therapies for emerging infectious diseases with a pipeline that includes product candidates for bacterial and viral infections, including pan-filovirus immunotherapeutics and vaccines, vaccines for Staphylococcal infections, and a variety of other product candidates for emerging viruses.
Missing: Integrated BioTherapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Integrated BioTherapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Integrated BioTherapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Integrated BioTherapeutics is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
838 items
Integrated BioTherapeutics Patents
Integrated BioTherapeutics has filed 17 patents.
The 3 most popular patent topics include:
- Immunology
- Bacterial toxins
- Immune system
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
6/13/2018 | 8/23/2022 | Immune system, Bacterial diseases, Bacterial toxins, Clusters of differentiation, Immunology | Grant |
Application Date | 6/13/2018 |
|---|---|
Grant Date | 8/23/2022 |
Title | |
Related Topics | Immune system, Bacterial diseases, Bacterial toxins, Clusters of differentiation, Immunology |
Status | Grant |
Latest Integrated BioTherapeutics News
May 16, 2022
Marseille, France) – The Global Hepatitis C Virus Envelope Protein E2 Market Intelligence Report is a valuable source of insightful data for business strategists. Provides an industry overview with growth analysis and historical & future cost, revenue, demand and supply data (as applicable). Research analysts provide a detailed description of the value chain and analysis […] The post Hepatitis C Virus Envelope Protein E2 Market to Witness Huge Growth by 2029 |Aviragen Therapeutics Inc, Integrated BioTherapeutics Inc, appeared first on Archyworldys.
Integrated BioTherapeutics Frequently Asked Questions (FAQ)
When was Integrated BioTherapeutics founded?
Integrated BioTherapeutics was founded in 2005.
Where is Integrated BioTherapeutics's headquarters?
Integrated BioTherapeutics's headquarters is located at 4 Research Court, Rockville.
What is Integrated BioTherapeutics's latest funding round?
Integrated BioTherapeutics's latest funding round is Unattributed - II.
How much did Integrated BioTherapeutics raise?
Integrated BioTherapeutics raised a total of $8.78M.
Who are the investors of Integrated BioTherapeutics?
Investors of Integrated BioTherapeutics include National Cancer Institute and National Institute of Allergy and Infectious Diseases.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.